Stay updated on ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial
Sign up to get notified when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.

Latest updates to the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a new Revision: v3.3.2 and removed Revision: v3.2.0 in the page's release notes area.SummaryDifference0.0%

- Check20 days agoChange DetectedDeletion of the government funding notice banner; a general site status message that does not affect the trial details.SummaryDifference0.3%

- Check34 days agoChange DetectedNo core content, eligibility criteria, or study design changes were observed; only updates to metadata such as the last update date are present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedAdded new dates (2025-10-08, 2025-11-30, 2025-10-07) and removed older dates (2025-09-10, 2025-08-30, 2025-09-08). This indicates updated timing information but no changes to core content or pricing.SummaryDifference0.4%

- Check63 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference3%

- Check70 days agoChange DetectedIntroduces version v3.1.0 and removes two disease topic entries (Mammary Neoplasms, Animal; Animal Diseases) indicating a reorganization and an updated release.SummaryDifference0.2%

Stay in the know with updates to ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.